Cranial mononeuropathy VII is a neurological disorder caused by damage to the seventh nerve in the skull (cranial nerve VII).
See also: Bell's palsy
Cranial mononeuropathy VII is a mononeuropathy (damage to a single nerve) that involves the seventh cranial (facial) nerve, the nerve that controls movement of the muscles of the face.
This nerve, located in the skull, also contributes to sensation in the ear canal and the sense of taste. Isolated facial nerve damage may occur with localized lesions, such as a tumor, that put pressure on the facial nerve. Cranial mononeuropathy VII may also be caused by HIV infection, sarcoidosis, Lyme disease. It may have no identifiable cause.
Bell's palsy is an acute form of Cranial mononeuropathy VII .
An examination will show facial drooping that may be on one side of the face or isolated to the forehead, eyelid, or mouth. Examination of the tympanic membrane in the ear may reveal vesicles.
A blood test may be done to check for Lyme disease. If a more systemic cause is suspected, a lumbar puncture may be performed. If a tumor compressing the nerve is suspected, an MRI of the head may be done. Other tests may be done to rule out a stroke or other neurological problems.
Identification and treatment of the underlying cause (if it can be identified) may relieve symptoms for some people. The disorder may disappear on its own depending on the severity of damage to the nerve.
Corticosteroids may reduce swelling and relieve pressure on the facial nerve. Acyclovir, an antiviral agent, is used in conjunction with steroids. Lubricating eye drops or eye ointments may be recommended to protect the eye if it cannot be closed completely.
The eye may need to be patched during sleep to protect it.
Surgery to decompress the facial nerve may be recommended if a tumor is identified.
The outcome varies. Some patients recover completely; others experience a permanent loss of facial movement.
Call your health care provider if facial drooping or other symptoms of cranial mononeuropathy VII occur.
Prompt treatment of lesions that compress the facial nerve may reduce the risk of cranial mononeuropathy VII in some cases.